Feferkorn, I. http://orcid.org/0000-0002-9772-3613
Santos-Ribeiro, S.
Ubaldi, F. M.
Velasco, J. G.
Ata, B.
Blockeel, C.
Conforti, A.
Esteves, S. C.
Fatemi, H. M.
Gianaroli, L.
Grynberg, M.
Humaidan, P.
Lainas, G.T
La Marca, A.
Craig, L. B.
Lathi, R.
Norman, R. J.
Orvieto, R.
Paulson, R.
Pellicer, A.
Polyzos, N. P.
Roque, M.
Sunkara, S. K.
Tan, S. L.
Urman, B.
Venetis, C.
Weissman, A.
Yarali, H.
Dahan, M. H.
Article History
Received: 29 March 2023
Accepted: 15 August 2023
First Online: 15 September 2023
Change Date: 11 December 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s10815-023-03003-7
Declarations
:
: All declarations of interest are outside the submitted work. Peter Humaidan reports reception of lecture honoraria from Merck, Gedeon Richter, and IBSA. Antonio La Marca reports reception of consulting fees from Merck, Organon, Ferring, Gedeon Richter, Theramex, Beckman Coulter, and Roche. Samuel Santos-Ribeiro reports reception of research funding from Roche Diagnostics, Organon, and Theramex; reception of consulting fees from Organon, MSD, and Ferring; honoraria for lectures from Ferring, Besins, MSD/Organon, Theramex, and Gedeon Richter; reception of equipment materials or other services from Roche Diagnostics and Ferring; and is deputy of the SQART SIG in ESHRE. Alessandro Conforti reports reception of grants from the University of Naples Federico II; reception honoraria from Medea, Event Planet, and Merck. Baris Ata reports reception of consulting fees from Merck GmBH–Turkey; reception of payment or honoraria from Abbott, Merck GmBH, and Ferring; reception of support for attending meetings or travel from IBSA; is president of the Turkish Society of Reproductive Medicine; and is an executive committee member of ESHRE. Juan Garcia Velasco reports reception of payment or honoraria for lectures or educational events from Merck, Ferring, MSD, Organon, Theramex, and Gedeon Richter. George Lainas reports reception of payment or honoraria for lectures or educational events from Merck and Ferring, payment for expert testimony from Merck, and support for attending meetings from ESHRE. He also participated in data safety monitoring or advisory board of Merck. Filippo Maria Ubaldi is the scientific director of GeneraLife and minority shareholder of the company. He is also the president of SIFES-MR (the Italian Society of Fertility, Sterility and Reproductive Medicine) and a member of the scientific board of Medea. In the last 3 years, F.M. Ubaldi has received honoraria or consultation fees from Merck, MSD, Ferring, Gedeon Richter, Organon, and IBSA. Sesh Sunkara reports reception of payment or honoraria for lectures from Merck Ferring and MSD. Raoul Orvieto reports reception of consulting fees from Merck and Ferring and payment or honoraria for lectures from Merck and Ferring. Nikolaos Polyzos reports reception of grants or contracts from Merck Serono, IBSA, Organon, Ferring, Roche, Theramex, Besins Healthcare, and Gedeon Richter and reception of consulting fees from Merck Serono, IBSA, Organon, Ferring, Besins Healthcare, and Gedeon Richter. Hakan Yarali reports unrestricted grants from Merck, honoraria for lectures from Merck and IBSA, and support for attending meetings from Merck, IBSA, and Ferring. Human Fatemi reports receiving research grants from Merck Serono and Organon; consulting fees from Ferring Global; speaker honoraria from Organon, Merck Serono, and Ferring; and participation in data safety monitoring or advisory board for Ferring. Sandro Esteves reports unrestricted research grants from Merck KGaA; reception of consulting fees from Merck, MeD.E.A, and event planet; reception of honoraria for lectures from Merck, MeD.E.A, and event planet; has a patent on the ART calculator, is an unpaid advisory board member for Nature Reviews and for Urology, Is the Head, Department of Education and Research, Brazilian Society of Urology (São Paulo section; unpaid), and is the Co-chair, Male Infertility Special Interest Group, WHO Infertility Guidelines (unpaid). Craig LaTasha is a site investigator for Ferring Pharmaceuticals. He was an advisory board member for Ferring Pharmaceuticals. Ariel Weissman, Christophe Blockeel, Christos Venetis, Seang Lin Tan, Michael Dahan, Bulent Urman, RJ Norman, Richard Paulson, and Ido Feferkorn report no conflicts of interest.